Return On Equity ratio Analysis of Lyra Therapeutics Inc - Deep Dive
Latest FY ROE
Period Ending - Dec-23
Very Poor ROE
-69.07
Period Ending - Dec-22
Very Poor ROE
-68.45
Growth
-0.897 %
Trailing Twelve Months ROE
Period Ending - Dec-23
Very Poor ROE
-82.82
Most recent Quarter ROE
Period Ending - Mar-24
Very Poor ROE
-28.97
ROE Analysis of Lyra Therapeutics Inc
ROE Ratio of Lyra Therapeutics Inc with value of -82.82 means is not able to effectively utilize its Shareholders Fund in order to generate a profit in trailing twelve months. |
ROE Ratio of Lyra Therapeutics Inc with value of -28.97 means is not able to effectively utilize its Shareholders Fund in order to generate a profit in latest Quarter ending on Mar-24. |
ROE Ratio of LYRA has fallen by -0.897 % Compared to previous Financial Year. |
ROE Ratio with value of -29.70 was highest in Year Dec-20 in last Five Years. |
ROE Ratio with value of -222.52 was lowest in Year Dec-19 in last Five Years. |
Latest ROE Ratio with value of -69.07 is Greater than Average ROE of -103.31 in last five years. |
ROE of Lyra Therapeutics Inc is negative because of poor net profit in last Financial Year , last Quarter and also in last twelve Months. |
Other ROE Related Info of LYRA that may interest you.
Lyra Therapeutics Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
LYRA | 0.328 | 0.3316 | 1.09 % | Biotechnology |
Defination of Return On Equity
The Return on Equity (ROE) is a profitability metric that measures a company's ability to generate profits using its shareholder's fund. ROE is calculated by dividing Net Income by Shareholders' Fund. more ..ROE Related Ratios
ReturnOnAsset | NetProfitMargin |
Tsr Profitability Index
Poor Profitability Stock |
FY - Historical Return On Equity of Lyra Therapeutics Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 |
---|---|---|---|---|---|---|
ROE | -69.07 | -68.45 | -126.80 | -29.70 | -222.52 | 0 |
Change | -0.897 % | 46.02 % | -326.88 % | 86.65 % |
FY Chart of Return On Equity of Lyra Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)